Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/11/2017
SIETES contiene 92130 citas

 
 
 1 a 14 de 14 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Tricco AC, Thomas SM, Veroniki AA, Hamid JS, Cogo E, Strifler L, Khan PA, Robson R, Sibley KM, MacDonald H, Riva JJ, Thavorn K, Wilson C, Holroyd-Leduc J, Kerr GD, Feldman F, Majumdar SR, Jaglal SB, Hui W, Straus SE. Comparisons of interventions for preventing falls in older adults. A systematic review and meta-analysis. JAMA 2017;318:1687-99. [Ref.ID 102139]
2.Tiene citas relacionadas Cita con resumen
Zannad F, Cannon CP, Cushman WC, Bakris GL, Menon V, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Lam H, White WB, for the EXAMINE Investigators. Heart failure and mortality ocutcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Lancet 2015;385:2067-76. [Ref.ID 99158]
3. Cita con resumen
Tricco AC, Ashoor HM, Antony J, Beyene J, Veroniki AA, Isaranuwatchai W, Harrington A, Wilson C, Tsouros S, Soobiah C, Yu CH, Hutton B, Hoch JS, Hemmelgarn BR, Moher D, Majumdar SR, Straus SE. Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. BMJ 2014;349:g5459. [Ref.ID 98278]
4.Tiene citas relacionadas Cita con resumen
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F, for the EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369:1327-35. [Ref.ID 96331]
5.Tiene citas relacionadas Cita con resumen
Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russsell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes. The SANDS randomized trial. JAMA 2008;299:1678-89. [Ref.ID 82594]
7.Tiene citas relacionadas Cita con resumen
Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Annaissie E, Wilson C, Dhodapkar M, Zeldis J, Barlogie B. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;341:1565-71. [Ref.ID 47694]
8.
Wilson C. CJD leads to upheaval in UK blood products market. Scrip 1998;2314:22. [Ref.ID 37381]
9. Cita con resumen
Wilson C. Safety concerns over Lundbeck's sertindole "groundless". Scrip 1997;2276:20-1. [Ref.ID 34841]
10.
Wilson C, Imrie CW. Current concepts in the management of pancreatitis. Drugs 1991;41:358-66. [Ref.ID 16188]
11.
Russell M A H, Wilson C, Taylor C, Baker CD. Smoking habits of men and women. BMJ 1980;281:17-20. [Ref.ID 6008]
12.
Russell M A H, Wilson C, Patel U A, Cole PV, Feyerabend C. Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. BMJ 1973;4:512-6. [Ref.ID 1430]
13. Cita con resumen
Russell M A H, Wilson C, Cole PV, Idle M, Feyerabend C. Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes. Lancet 1973;2:687-90. [Ref.ID 1157]
14. Cita con resumen
Russell M A H, Wilson C, Patel U A, Feyerabend C, Cole PV. Plasma nicotine levels after smoking cigarettes with high, medium and low nicotine yields. BMJ 1975;4:414-6. [Ref.ID 1081]
Seleccionar todas
 
 1 a 14 de 14